However, the switch to DTG/3TC was associated after 6 months with statistically higher levels both in CD4+ and CD8+ T lymphocytes with markers related to terminal differentiation and exhaustion and in non-classical monocytes, a population of cells that has been recently associated with endothelial dysfunction. The gene discussed is CD4; the disease is endothelial dysfunction.